Quantifying the changes in the tumour vascular micro-environment in spinal metastases treated with stereotactic body radiotherapy - a single arm prospective study

1Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 2006; 12(20 Pt 2): 6243s-9s. doi: 10.1158/1078-0432.CCR-06-0931 Coleman RE Clinical features of metastatic bone disease and risk of skeletal morbidity Clin Cancer Res 2006 1220 Pt 2 6243s 9 s 10.1158/1078-0432.CCR-06-093117062708Open DOISearch in Google Scholar

2Kumar N, Malhotra R, Zaw AS, Maharajan K, Naresh N, Kumar A, et al. Evolution in treatment strategy for metastatic spine disease: presently evolving modalities. Eur J Surg Oncol 2017; 43: 1784-801. doi: 10.1016/j. ejso.2017.05.006 Kumar N Malhotra R Zaw AS Maharajan K Naresh N Kumar A et al Evolution in treatment strategy for metastatic spine disease: presently evolving modalities Eur J Surg Oncol 2017 43 1784 801 10.1016/j.ejso.2017.05.00628579359Open DOISearch in Google Scholar

3Kumar N, Zaw AS, Khine HE, Maharajan K, Wai KL, Tan B, et al. Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors. Ann Surg Oncol 2016; 23: 2079-86. doi: 10.1245/s10434-016-5092-8 Kumar N Zaw AS Khine HE Maharajan K Wai KL Tan B et al Blood loss and transfusion requirements in metastatic spinal tumor surgery: evaluation of influencing factors Ann Surg Oncol 2016 23 2079 86 10.1245/s10434-016-5092-826819232Open DOISearch in Google Scholar

4Clausen C, Dahl B, Frevert SC, Hansen LV, Nielsen MB, Lonn L. Preoperative embolization in surgical treatment of spinal metastases: single-blind, randomized controlled clinical trial of efficacy in decreasing intraoperative blood loss. J Vasc Interv Radiol 2015; 26: 402-12.e1. doi: 10.1016/j. jvir.2014.11.014 Clausen C Dahl B Frevert SC Hansen LV Nielsen MB Lonn L Preoperative embolization in surgical treatment of spinal metastases: single-blind, randomized controlled clinical trial of efficacy in decreasing intraoperative blood loss J Vasc Interv Radiol 2015 26 402 12 .e1 10.1016/j.jvir.2014.11.01425636672Open DOISearch in Google Scholar

5Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003; 300: 1155-9. doi: 10.1126/science.1082504 Garcia-Barros M Paris F Cordon-Cardo C Lyden D Rafii S Haimovitz-Friedman A et al Tumor response to radiotherapy regulated by endothelial cell apoptosis Science 2003 300 1155 9 10.1126/science.108250412750523Open DOISearch in Google Scholar

6Sathishkumar S, Boyanovsky B, Karakashian AA, Rozenova K, Giltiay NV, Kudrimoti M, et al. Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis. Cancer Biol Ther 2005; 4: 979-86. doi: 10.4161/cbt.4.9.1915 Sathishkumar S Boyanovsky B Karakashian AA Rozenova K Giltiay NV Kudrimoti M et al Elevated sphingomyelinase activity and ceramide concentration in serum of patients undergoing high dose spatially fractionated radiation treatment: implications for endothelial apoptosis Cancer Biol Ther 2005 4 979 86 10.4161/cbt.4.9.191516096366Open DOISearch in Google Scholar

7Song CW, Kim MS, Cho LC, Dusenbery K, Sperduto PW. Radiobiological basis of SBRT and SRS. Int J Clin Oncol 2014; 19: 570-8. doi: 10.1007/s10147-014-0717-z Song CW Kim MS Cho LC Dusenbery K Sperduto PW Radiobiological basis of SBRT and SRS Int J Clin Oncol 2014 19 570 8 10.1007/s10147-014-0717-z24993673Open DOISearch in Google Scholar

8Chu S, Karimi S, Peck KK, Yamada Y, Lis E, Lyo J, et al. Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy. Spine 2013; 38: E1418-24 doi: 10.1097/BRS.0b013e3182a40838 Chu S Karimi S Peck KK Yamada Y Lis E Lyo J et al Measurement of blood perfusion in spinal metastases with dynamic contrast-enhanced magnetic resonance imaging: evaluation of tumor response to radiation therapy Spine 2013 38 E1418 24 10.1097/BRS.0b013e3182a40838575765823873238Open DOISearch in Google Scholar

9Kumar KA, Peck KK, Karimi S, Lis E, Holodny AI, Bilsky MH, et al. A pilot study evaluating the use of dynamic contrast-enhanced perfusion MRI to predict local recurrence after radiosurgery on spinal metastases. Technol Cancer Res Treat 2017; 16: 857-65. doi: 10.1177/1533034617705715 Kumar KA Peck KK Karimi S Lis E Holodny AI Bilsky MH et al A pilot study evaluating the use of dynamic contrast-enhanced perfusion MRI to predict local recurrence after radiosurgery on spinal metastases Technol Cancer Res Treat 2017 16 857 65 10.1177/1533034617705715576204128449626Open DOISearch in Google Scholar

10Lis E, Saha A, Peck KK, Zatcky J, Zelefsky MJ, Yamada Y, et al. Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy. Neurosurg Focus 2017; 42: E9. doi: 10.3171/2016.9.FOCUS16378 Lis E Saha A Peck KK Zatcky J Zelefsky MJ Yamada Y et al Dynamic contrast-enhanced magnetic resonance imaging of osseous spine metastasis before and 1 hour after high-dose image-guided radiation therapy Neurosurg Focus 2017 42 E9 10.3171/2016.9.FOCUS16378553036428041318Open DOISearch in Google Scholar

11Lee JH, Yoo GS, Yoon YC, Park HC, Kim HS. Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma. Sci Rep 2021; 11: 10459. doi: 10.1038/s41598-021-90065-1 Lee JH Yoo GS Yoon YC Park HC Kim HS Diffusion-weighted and dynamic contrast-enhanced magnetic resonance imaging after radiation therapy for bone metastases in patients with hepatocellular carcinoma Sci Rep 2021 11 10459 10.1038/s41598-021-90065-1Open DOISearch in Google Scholar

12Yankeelov TE, Gore JC. Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples. Curr Med Imaging Rev 2009; 3: 91-107. doi: 10.2174/157340507780619179 Yankeelov TE Gore JC Dynamic contrast enhanced magnetic resonance imaging in oncology: Theory, data acquisition, analysis, and examples Curr Med Imaging Rev 2009 3 91 107 10.2174/157340507780619179Open DOISearch in Google Scholar

13Koh TS, Bisdas S, Koh DM, Thng CH. Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI. J Magn Reson Imaging 2011; 34: 1262-76. doi: 10.1002/jmri.22795 Koh TS Bisdas S Koh DM Thng CH Fundamentals of tracer kinetics for dynamic contrast-enhanced MRI J Magn Reson Imaging 2011 34 1262 76 10.1002/jmri.22795Open DOISearch in Google Scholar

14Cox BW, Spratt DE, Lovelock M, Bilsky MH, Lis E, Ryu S, et al. International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 2012; 83: e597-605. doi: 10.1016/j.ijrobp.2012.03.009 Cox BW Spratt DE Lovelock M Bilsky MH Lis E Ryu S et al International Spine Radiosurgery Consortium consensus guidelines for target volume definition in spinal stereotactic radiosurgery Int J Radiat Oncol Biol Phys 2012 83 e597 605 10.1016/j.ijrobp.2012.03.009Open DOISearch in Google Scholar

15Sahgal A, Weinberg V, Ma L, Chang E, Chao S, Muacevic A, et al. Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice. Int J Radiat Oncol Biol Phys 2013; 85: 341-7 doi: 10.1016/j.ijrobp.2012.05.007 Sahgal A Weinberg V Ma L Chang E Chao S Muacevic A et al Probabilities of radiation myelopathy specific to stereotactic body radiation therapy to guide safe practice Int J Radiat Oncol Biol Phys 2013 85 341 7 10.1016/j.ijrobp.2012.05.007Open DOISearch in Google Scholar

16Costelloe CM, Chuang HH, Madewell JE, Ueno NT. Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST. J Cancer 2010; 1: 80-92. doi: 10.7150/jca.1.80. Costelloe CM Chuang HH Madewell JE Ueno NT Cancer response criteria and bone metastases: RECIST 1.1, MDA and PERCIST J Cancer 2010 1 80-92 10.7150/jca.1.80.Open DOISearch in Google Scholar

17Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999; 10: 223-32. doi: 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s Tofts PS Brix G Buckley DL Evelhoch JL Henderson E Knopp MV et al Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols J Magn Reson Imaging 1999 10 223 32 10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-SSearch in Google Scholar

18Khalifa F, Soliman A, El-Baz A, Abou El-Ghar M, El-Diasty T, Gimel’farb G, et al. Models and methods for analyzing DCE-MRI: a review. Med Phys 2014; 41: 124301 doi: 10.1118/1.4898202 Khalifa F Soliman A El-Baz A Abou El-Ghar M El-Diasty T Gimel’farb G et al Models and methods for analyzing DCE-MRI: a review Med Phys 2014 41 124301 10.1118/1.4898202Open DOISearch in Google Scholar

19Dubois N, Rio E, Ripoche N, Ferchaud-Roucher V, Gaugler MH, Campion L, et al. Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan. Radiother Oncol 2016; 119: 229-35. doi: 10.1016/j. radonc.2016.03.014 Dubois N Rio E Ripoche N Ferchaud-Roucher V Gaugler MH Campion L et al Plasma ceramide, a real-time predictive marker of pulmonary and hepatic metastases response to stereotactic body radiation therapy combined with irinotecan Radiother Oncol 2016 119 229 35 10.1016/j.radonc.2016.03.014Open DOISearch in Google Scholar